← Eichor · All briefs

NCT04227106 — Epidermolysis Bullosa trial site landscape

Public-registry site landscape for NCT04227106, a Epidermolysis Bullosa study sponsored by Abeona Therapeutics, Inc. All data below is from public sources; Eichor is not affiliated with the sponsor.

TrialNCT04227106 (registry record)
SponsorAbeona Therapeutics, Inc
Condition(s)Epidermolysis Bullosa; Recessive Dystrophic Epidermolysis Bullosa
PhasePHASE3
Listed sites2
Site countriesUnited States

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT04227106 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.